Table:
begin	end	state
1	30	non-cytoplasmic
31	52	transmembrane
53	75	cytoplasmic
76	105	transmembrane
106	108	non-cytoplasmic
109	126	transmembrane
127	165	cytoplasmic
166	186	transmembrane
187	205	non-cytoplasmic
206	225	transmembrane
226	233	cytoplasmic
234	255	transmembrane
256	260	non-cytoplasmic
261	284	transmembrane
285	320	cytoplasmic
321	345	transmembrane
346	371	non-cytoplasmic
372	396	transmembrane
397	402	cytoplasmic
403	426	transmembrane
427	435	non-cytoplasmic
436	455	transmembrane
456	481	cytoplasmic

Input:
>WP_011371858.1 NCBI__GCF_000012965.1:WP_011371858.1
MGEFFSGVNSFLEAALFFDILFGMVEGVKLPFLVVWLISGGIYLTLLTKFINLRMFKHSF
DILRGKYRTVDDVGEISSFGALTTALSATVGLGNIAGVALAVALGGPGATFWMIVAGFLG
MSLKFTEVTLSLQHRVFLKDGTVMGGAMEYLSRGLAEKGYAKFGKILSLIFAVFMIGGAI
GGGNVFQVSQALGVVSQEVEFFDKFPIIFGILIAVFVGFVIIGGVTRIAKITEFLVPIMA
IIYVSASLWILAYHFEKIDDAISIIFHEAFSTSALYGGVAGSIVHGFQRAVFSSEAGIGS
SPVAHAPVKTKYPVRQGLVALYEPFIDTIVICTMTALVIVITGVYEHDGAYMALIEAKEG
AALTSAAYGTVISWFPIILSISITLFAFSTIIAWAYYGERAWVYLFGSTYSIIYKLSFLL
LIIIGTVVNTAVLVDFSFMLFLTMSLPNILGLFILSKDVKRALEEYLVKLKSGELDREAI
R

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server